Vault-13

RA CAPITAL MANAGEMENT, L.P.

BOSTON, MA · CIK 1346824 · 13F filing filed 2022-08-15

SEC-registered investment adviser since 2012 · limited partnership

As an employer

Where they work

people there (dot area)number not reportedmain officeHover or tap a dot. Australian and UK companies are placed at their business or registered address, with their staff across the whole country.

Offices

From Form ADV: the main office and the other offices where it does advisory work (at most the 25 largest), with the people doing investment work at each. “About” is worked out: the firm's investment staff less its other offices. Each city links to the other managers there.

CityCountryPeople
Boston, MA (main office)United States United Statesabout 89
New York, NYUnited States United States4
San Francisco, CAUnited States United States2

Map: places from GeoNames (CC BY 4.0), outlines from Natural Earth.

$3.8bn reported value -18.2% vs Q1 2022
88positions
47.2%in top 10
14 new 9 added 11 reduced 22 sold out vs Q1 2022

Holdings, Q2 2022

The small lines show how much was held over the last 4 quarters (adjusted for stock splits).

#SecurityTickerShares Value% of portfolioChangeShares change
1 ASCENDIS PHARMA A/S SPONSORED ADR SPONSORED ADR 7,567,900 $703.5m18.76% 18.76% UnchangedShares held: Q3 2021 7.4m, Q4 2021 7.6m, Q1 2022 7.6m, Q2 2022 7.6m
2 BIOGEN INC COM BIIB BIIB 727,024 $148.3m3.95% 3.95% UnchangedShares held: Q3 2021 0, Q4 2021 0, Q1 2022 727.0k, Q2 2022 727.0k
3 CYTEK BIOSCIENCES INC COM CTKB CTKB 13,381,054 $143.6m3.83% 3.83% UnchangedShares held: Q3 2021 9.6m, Q4 2021 9.6m, Q1 2022 13.4m, Q2 2022 13.4m
4 AEROVATE THERAPEUTICS INC COM COM 8,263,982 $129.2m3.44% 3.44% UnchangedShares held: Q3 2021 8.3m, Q4 2021 8.3m, Q1 2022 8.3m, Q2 2022 8.3m
5 DAY ONE BIOPHARMACEUTICALS I COM COM 7,040,622 $126.0m3.36% 3.36% AddedShares held: Q3 2021 5.0m, Q4 2021 5.0m, Q1 2022 6.1m, Q2 2022 7.0m +980.5k +980,532 16.2%
6 TRAVERE THERAPEUTICS INC COM TVTX TVTX 4,922,941 $119.3m3.18% 3.18% UnchangedShares held: Q3 2021 5.6m, Q4 2021 5.6m, Q1 2022 4.9m, Q2 2022 4.9m
7 JANUX THERAPEUTICS INC COM JANX JANX 8,670,644 $105.9m2.82% 2.82% UnchangedShares held: Q3 2021 8.7m, Q4 2021 8.7m, Q1 2022 8.7m, Q2 2022 8.7m
8 VAXCYTE INC COM PCVX PCVX 4,581,203 $99.7m2.66% 2.66% UnchangedShares held: Q3 2021 3.9m, Q4 2021 4.2m, Q1 2022 4.6m, Q2 2022 4.6m
9 IMMUNOGEN INC COM IMGN IMGN 21,741,458 $97.8m2.61% 2.61% UnchangedShares held: Q3 2021 18.4m, Q4 2021 20.2m, Q1 2022 21.7m, Q2 2022 21.7m
10 NKARTA INC COM NKTX NKTX 7,805,129 $96.2m2.56% 2.56% AddedShares held: Q3 2021 5.6m, Q4 2021 5.6m, Q1 2022 5.6m, Q2 2022 7.8m +2.2m +2,200,000 39.2%
11 BELLUS HEALTH INC NEW COM NEW BLU BLU 10,230,274 $94.5m2.52% 2.52% UnchangedShares held: Q3 2021 0, Q4 2021 10.2m, Q1 2022 10.2m, Q2 2022 10.2m
12 ITEOS THERAPEUTICS INC COM ITOS ITOS 4,417,259 $91.0m2.43% 2.43% UnchangedShares held: Q3 2021 4.4m, Q4 2021 4.4m, Q1 2022 4.4m, Q2 2022 4.4m
13 VERU INC COM COM 7,900,000 $89.3m2.38% 2.38% NewShares held: Q3 2021 0, Q4 2021 0, Q1 2022 0, Q2 2022 7.9m
14 DICE THERAPEUTICS INC COM COM 5,208,911 $80.8m2.16% 2.16% UnchangedShares held: Q3 2021 5.2m, Q4 2021 5.2m, Q1 2022 5.2m, Q2 2022 5.2m
15 PEPGEN INC COM PEPG PEPG 8,131,952 $80.8m2.15% 2.15% NewShares held: Q3 2021 0, Q4 2021 0, Q1 2022 0, Q2 2022 8.1m
16 FORMA THERAPEUTICS HLDGS INC SHS SHS 9,011,651 $62.1m1.66% 1.66% UnchangedShares held: Q3 2021 9.0m, Q4 2021 9.0m, Q1 2022 9.0m, Q2 2022 9.0m
17 ACLARIS THERAPEUTICS INC COM ACRS ACRS 4,398,453 $61.4m1.64% 1.64% AddedShares held: Q3 2021 0, Q4 2021 0, Q1 2022 1.8m, Q2 2022 4.4m +2.6m +2,580,645 142.0%
18 POINT BIOPHARMA GLOBAL INC COM COM 9,003,018 $61.3m1.63% 1.63% UnchangedShares held: Q3 2021 8.9m, Q4 2021 9.0m, Q1 2022 9.0m, Q2 2022 9.0m
19 CELLDEX THERAPEUTICS INC NEW COM NEW CLDX CLDX 2,075,000 $55.9m1.49% 1.49% UnchangedShares held: Q3 2021 1.6m, Q4 2021 1.8m, Q1 2022 2.1m, Q2 2022 2.1m
20 WAVE LIFE SCIENCES LTD SHS 96663EUR 96663EUR 17,202,009 $55.9m1.49% 1.49% AddedShares held: Q3 2021 7.8m, Q4 2021 7.8m, Q1 2022 7.8m, Q2 2022 17.2m +9.4m +9,426,802 121.2%
21 VOR BIOPHARMA INC COM COM 11,120,973 $55.3m1.47% 1.47% UnchangedShares held: Q3 2021 11.1m, Q4 2021 11.1m, Q1 2022 11.1m, Q2 2022 11.1m
22 KINNATE BIOPHARMA INC COM KNTE KNTE 4,264,144 $53.8m1.43% 1.43% UnchangedShares held: Q3 2021 3.6m, Q4 2021 3.6m, Q1 2022 4.3m, Q2 2022 4.3m
23 TYRA BIOSCIENCES INC COM TYRA TYRA 7,236,454 $51.7m1.38% 1.38% UnchangedShares held: Q3 2021 7.2m, Q4 2021 7.2m, Q1 2022 7.2m, Q2 2022 7.2m
24 GH RESEARCH PLC ORDINARY SHARES GHRS GHRS 4,898,373 $48.9m1.30% 1.30% AddedShares held: Q3 2021 3.0m, Q4 2021 2.8m, Q1 2022 4.8m, Q2 2022 4.9m +71.0k +71,043 1.5%
25 GERON CORP COM GERN GERN 30,126,299 $46.7m1.25% 1.25% UnchangedShares held: Q3 2021 30.1m, Q4 2021 30.1m, Q1 2022 30.1m, Q2 2022 30.1m
26 NATERA INC COM NTRA NTRA 1,310,289 $46.4m1.24% 1.24% UnchangedShares held: Q3 2021 0, Q4 2021 0, Q1 2022 1.3m, Q2 2022 1.3m
27 ACUMEN PHARMACEUTICALS INC COM ABOS ABOS 9,770,773 $45.9m1.22% 1.22% UnchangedShares held: Q3 2021 9.8m, Q4 2021 9.8m, Q1 2022 9.8m, Q2 2022 9.8m
28 NANOSTRING TECHNOLOGIES INC COM NSTG NSTG 3,584,478 $45.5m1.21% 1.21% NewShares held: Q3 2021 0, Q4 2021 0, Q1 2022 0, Q2 2022 3.6m
29 RXSIGHT INC COM RXST RXST 3,052,796 $43.0m1.15% 1.15% UnchangedShares held: Q3 2021 3.1m, Q4 2021 3.1m, Q1 2022 3.1m, Q2 2022 3.1m
30 ENANTA PHARMACEUTICALS INC COM ENTA ENTA 896,724 $42.4m1.13% 1.13% ReducedShares held: Q3 2021 0, Q4 2021 0, Q1 2022 964.2k, Q2 2022 896.7k -67.5k -67,488 -7.0%
31 CLIMB BIO INC COM CLYM CLYM 13,150,849 $39.7m1.06% 1.06% UnchangedShares held: Q3 2021 13.2m, Q4 2021 13.2m, Q1 2022 13.2m, Q2 2022 13.2m
32 RELMADA THERAPEUTICS INC COM RLMD RLMD 2,000,000 $38.0m1.01% 1.01% UnchangedShares held: Q3 2021 0, Q4 2021 2.0m, Q1 2022 2.0m, Q2 2022 2.0m
33 INSTIL BIO INC COM COM 7,670,793 $35.4m0.94% 0.94% AddedShares held: Q3 2021 4.9m, Q4 2021 4.9m, Q1 2022 4.9m, Q2 2022 7.7m +2.8m +2,800,000 57.5%
34 ICOSAVAX INC COM COM 5,963,565 $34.2m0.91% 0.91% UnchangedShares held: Q3 2021 5.8m, Q4 2021 5.8m, Q1 2022 6.0m, Q2 2022 6.0m
35 AVIDITY BIOSCIENCES INC COM RNA RNA 2,167,391 $31.5m0.84% 0.84% UnchangedShares held: Q3 2021 423.6k, Q4 2021 423.6k, Q1 2022 2.2m, Q2 2022 2.2m
36 DESIGN THERAPEUTICS INC COM DSGN DSGN 2,186,636 $30.6m0.82% 0.82% UnchangedShares held: Q3 2021 2.2m, Q4 2021 2.2m, Q1 2022 2.2m, Q2 2022 2.2m
37 AN2 THERAPEUTICS INC COM ANTX ANTX 3,748,389 $29.1m0.77% 0.77% AddedShares held: Q3 2021 0, Q4 2021 0, Q1 2022 3.7m, Q2 2022 3.7m +81.7k +81,726 2.2%
38 ROCKET PHARMACEUTICALS INC COM RCKT RCKT 2,107,149 $29.0m0.77% 0.77% UnchangedShares held: Q3 2021 2.1m, Q4 2021 2.1m, Q1 2022 2.1m, Q2 2022 2.1m
39 EYEPOINT PHARMACEUTICALS INC COM NEW EYPT EYPT 3,370,506 $26.5m0.71% 0.71% UnchangedShares held: Q3 2021 2.2m, Q4 2021 3.4m, Q1 2022 3.4m, Q2 2022 3.4m
40 89BIO INC COM ETNB ETNB 7,782,669 $25.1m0.67% 0.67% AddedShares held: Q3 2021 5.0m, Q4 2021 5.0m, Q1 2022 5.0m, Q2 2022 7.8m +2.8m +2,816,900 56.7%
41 SATSUMA PHARMACEUTICALS INC COM STSA STSA 5,914,252 $24.5m0.65% 0.65% UnchangedShares held: Q3 2021 5.9m, Q4 2021 5.9m, Q1 2022 5.9m, Q2 2022 5.9m
42 PMV PHARMACEUTICALS INC COM PMVP PMVP 1,710,265 $24.4m0.65% 0.65% UnchangedShares held: Q3 2021 1.7m, Q4 2021 1.7m, Q1 2022 1.7m, Q2 2022 1.7m
43 VERA THERAPEUTICS INC CL A VERA VERA 1,578,820 $21.5m0.57% 0.57% ReducedShares held: Q3 2021 0, Q4 2021 0, Q1 2022 2.0m, Q2 2022 1.6m -387.3k -387,264 -19.7%
44 VERONA PHARMA PLC SPONSORED ADS VRNA VRNA 5,100,000 $21.4m0.57% 0.57% UnchangedShares held: Q3 2021 5.1m, Q4 2021 5.1m, Q1 2022 5.1m, Q2 2022 5.1m
45 RHYTHM PHARMACEUTICALS INC COM RYTM RYTM 4,871,067 $20.2m0.54% 0.54% UnchangedShares held: Q3 2021 4.9m, Q4 2021 4.9m, Q1 2022 4.9m, Q2 2022 4.9m
46 TENAYA THERAPEUTICS INC COM TNYA TNYA 3,551,508 $20.0m0.53% 0.53% UnchangedShares held: Q3 2021 3.6m, Q4 2021 3.6m, Q1 2022 3.6m, Q2 2022 3.6m
47 DYNE THERAPEUTICS INC COM DYN DYN 2,805,045 $19.3m0.51% 0.51% UnchangedShares held: Q3 2021 2.8m, Q4 2021 2.8m, Q1 2022 2.8m, Q2 2022 2.8m
48 HILLEVAX INC COM COM 1,760,019 $19.2m0.51% 0.51% NewShares held: Q3 2021 0, Q4 2021 0, Q1 2022 0, Q2 2022 1.8m
49 GUARDANT HEALTH INC COM GH GH 476,380 $19.2m0.51% 0.51% UnchangedShares held: Q3 2021 0, Q4 2021 0, Q1 2022 476.4k, Q2 2022 476.4k
50 PARDES BIOSCIENCES INC COM COM 6,175,038 $19.0m0.51% 0.51% UnchangedShares held: Q3 2021 0, Q4 2021 3.1m, Q1 2022 6.2m, Q2 2022 6.2m
51 WEREWOLF THERAPEUTICS INC COM HOWL HOWL 4,291,881 $17.6m0.47% 0.47% UnchangedShares held: Q3 2021 4.3m, Q4 2021 4.3m, Q1 2022 4.3m, Q2 2022 4.3m
52 DA32 LIFE SCNCE TEC ACQSTN C CLASS A COM CLASS A COM 1,500,000 $14.5m0.39% 0.39% UnchangedShares held: Q3 2021 1.5m, Q4 2021 1.5m, Q1 2022 1.5m, Q2 2022 1.5m
53 CONCERT PHARMACEUTICALS INC COM CNCE CNCE 3,307,203 $13.9m0.37% 0.37% AddedShares held: Q3 2021 3.0m, Q4 2021 3.0m, Q1 2022 3.0m, Q2 2022 3.3m +273.6k +273,600 9.0%
54 MILESTONE PHARMACEUTICALS IN COM MIST MIST 2,246,503 $13.8m0.37% 0.37% UnchangedShares held: Q3 2021 2.2m, Q4 2021 2.2m, Q1 2022 2.2m, Q2 2022 2.2m
55 ACHILLES THERAPEUTICS PLC SPONSORED ADS SPONSORED ADS 5,014,687 $12.6m0.34% 0.34% UnchangedShares held: Q3 2021 5.0m, Q4 2021 5.0m, Q1 2022 5.0m, Q2 2022 5.0m
56 BCLS ACQUISITION CORP COM CL A COM CL A 1,250,000 $12.4m0.33% 0.33% UnchangedShares held: Q3 2021 1.2m, Q4 2021 1.2m, Q1 2022 1.2m, Q2 2022 1.2m
57 OTONOMY INC COM OTIC OTIC 5,600,000 $11.6m0.31% 0.31% UnchangedShares held: Q3 2021 1.6m, Q4 2021 5.6m, Q1 2022 5.6m, Q2 2022 5.6m
58 LIANBIO SPONSORED ADS LIANY LIANY 4,622,574 $10.0m0.27% 0.27% ReducedShares held: Q3 2021 0, Q4 2021 7.7m, Q1 2022 7.7m, Q2 2022 4.6m -3.0m -3,032,441 -39.6%
59 FRAZIER LIFESCIENCES ACQU CO UNIT 12/09/2025 UNIT 12/09/2025 1,000,000 $9.9m0.26% 0.26% UnchangedShares held: Q3 2021 1.0m, Q4 2021 1.0m, Q1 2022 1.0m, Q2 2022 1.0m
60 ARYA SCIENCES ACQUISITN CORP CLASS A ORD SHS CLASS A ORD SHS 1,000,000 $9.7m0.26% 0.26% UnchangedShares held: Q3 2021 1.0m, Q4 2021 1.0m, Q1 2022 1.0m, Q2 2022 1.0m
61 RELAY THERAPEUTICS INC COM RLAY RLAY 549,055 $9.2m0.25% 0.25% UnchangedShares held: Q3 2021 0, Q4 2021 549.1k, Q1 2022 549.1k, Q2 2022 549.1k
62 IO BIOTECH INC COM IOBTQ IOBTQ 1,857,755 $8.7m0.23% 0.23% UnchangedShares held: Q3 2021 0, Q4 2021 1.9m, Q1 2022 1.9m, Q2 2022 1.9m
63 SOLID BIOSCIENCES INC COM COM 12,367,873 $7.6m0.20% 0.20% UnchangedShares held: Q3 2021 12.4m, Q4 2021 12.4m, Q1 2022 12.4m, Q2 2022 12.4m
64 5 01 ACQUISITION CORP COM CL A COM CL A 750,000 $7.4m0.20% 0.20% UnchangedShares held: Q3 2021 750.0k, Q4 2021 750.0k, Q1 2022 750.0k, Q2 2022 750.0k
65 SYNLOGIC INC COM COM 5,825,858 $6.7m0.18% 0.18% ReducedShares held: Q3 2021 6.7m, Q4 2021 6.7m, Q1 2022 6.7m, Q2 2022 5.8m -840.8k -840,808 -12.6%
66 BLACK DIAMOND THERAPEUTICS I COM BDTX BDTX 2,589,904 $6.4m0.17% 0.17% UnchangedShares held: Q3 2021 2.6m, Q4 2021 2.6m, Q1 2022 2.6m, Q2 2022 2.6m
67 CENTURY THERAPEUTICS INC COM IPSC IPSC 756,821 $6.4m0.17% 0.17% ReducedShares held: Q3 2021 914.1k, Q4 2021 914.1k, Q1 2022 914.1k, Q2 2022 756.8k -157.3k -157,273 -17.2%
68 HEALTH SCIENCES ACQ CORP 2 ORD SHS OBIO OBIO 625,000 $6.2m0.17% 0.17% UnchangedShares held: Q3 2021 625.0k, Q4 2021 625.0k, Q1 2022 625.0k, Q2 2022 625.0k
69 CONNECT BIOPHARMA HLDGS LTD ADS ADS 6,991,003 $6.1m0.16% 0.16% UnchangedShares held: Q3 2021 7.0m, Q4 2021 7.0m, Q1 2022 7.0m, Q2 2022 7.0m
70 BIOMEA FUSION INC COM BMEA BMEA 500,000 $6.0m0.16% 0.16% UnchangedShares held: Q3 2021 500.0k, Q4 2021 500.0k, Q1 2022 500.0k, Q2 2022 500.0k
71 ATHIRA PHARMA INC COM COM 1,878,000 $5.7m0.15% 0.15% NewShares held: Q3 2021 0, Q4 2021 0, Q1 2022 0, Q2 2022 1.9m
72 XILIO THERAPEUTICS INC COM COM 1,649,711 $4.8m0.13% 0.13% ReducedShares held: Q3 2021 0, Q4 2021 2.0m, Q1 2022 2.0m, Q2 2022 1.6m -352.5k -352,506 -17.6%
73 AADI BIOSCIENCE INC COM WHWK WHWK 383,028 $4.7m0.13% 0.13% NewShares held: Q3 2021 347.7k, Q4 2021 0, Q1 2022 0, Q2 2022 383.0k
74 STANDARD BIOTOOLS INC COM LAB LAB 1,987,589 $3.2m0.08% 0.08% NewShares held: Q3 2021 0, Q4 2021 0, Q1 2022 0, Q2 2022 2.0m
75 ENTERA BIO LTD SHS ENTX ENTX 2,353,000 $3.1m0.08% 0.08% UnchangedShares held: Q3 2021 2.4m, Q4 2021 2.4m, Q1 2022 2.4m, Q2 2022 2.4m
76 TERNS PHARMACEUTICALS INC COM COM 1,261,435 $3.1m0.08% 0.08% NewShares held: Q3 2021 0, Q4 2021 0, Q1 2022 0, Q2 2022 1.3m
77 BIOATLA INC COM BCAB BCAB 1,031,805 $2.9m0.08% 0.08% NewShares held: Q3 2021 0, Q4 2021 0, Q1 2022 0, Q2 2022 1.0m
78 ASTRIA THERAPEUTICS INC COM CATB CATB 760,857 $2.3m0.06% 0.06% ReducedShares held: Q3 2021 1.3m, Q4 2021 1.3m, Q1 2022 1.3m, Q2 2022 760.9k -501.3k -501,336 -39.7%
79 PYXIS ONCOLOGY INC COMMON STOCK PYXS PYXS 953,393 $2.3m0.06% 0.06% ReducedShares held: Q3 2021 0, Q4 2021 2.3m, Q1 2022 2.3m, Q2 2022 953.4k -1.3m -1,328,780 -58.2%
80 ADVERUM BIOTECHNOLOGIES INC COM COM 1,726,019 $2.1m0.06% 0.06% NewShares held: Q3 2021 0, Q4 2021 0, Q1 2022 0, Q2 2022 1.7m
81 LARIMAR THERAPEUTICS INC COM LRMR LRMR 1,031,482 $2.0m0.05% 0.05% ReducedShares held: Q3 2021 1.5m, Q4 2021 1.3m, Q1 2022 1.3m, Q2 2022 1.0m -250.4k -250,378 -19.5%
82 ORCHARD THERAPEUTICS PLC ADS ORTX ORTX 3,040,885 $1.8m0.05% 0.05% ReducedShares held: Q3 2021 11.0m, Q4 2021 9.7m, Q1 2022 9.7m, Q2 2022 3.0m -6.7m -6,653,904 -68.6%
83 CVRX INC COM CVRX CVRX 275,000 $1.7m0.04% 0.04% UnchangedShares held: Q3 2021 275.0k, Q4 2021 275.0k, Q1 2022 275.0k, Q2 2022 275.0k
84 SENSEI BIOTHERAPEUTICS INC COM SNSE SNSE 723,549 $1.6m0.04% 0.04% NewShares held: Q3 2021 0, Q4 2021 0, Q1 2022 0, Q2 2022 723.5k
85 OLEMA PHARMACEUTICALS INC COM OLMA OLMA 233,793 $952.0k0.03% 0.03% ReducedShares held: Q3 2021 2.2m, Q4 2021 2.2m, Q1 2022 504.5k, Q2 2022 233.8k -270.7k -270,712 -53.7%
86 BOLT BIOTHERAPEUTICS INC COM COM 450,141 $918.0k0.02% 0.02% NewShares held: Q3 2021 2.4m, Q4 2021 2.4m, Q1 2022 0, Q2 2022 450.1k
87 AVROBIO INC COM COM 559,600 $515.0k0.01% 0.01% NewShares held: Q3 2021 0, Q4 2021 0, Q1 2022 0, Q2 2022 559.6k
88 CALADRIUS BIOSCIENCES INC COM NEW NBS NBS 752,500 $399.0k0.01% 0.01% NewShares held: Q3 2021 0, Q4 2021 0, Q1 2022 0, Q2 2022 752.5k

Sold out since Q1 2022

SecurityTickerShares held beforeValue then
MIRATI THERAPEUTICS INC MRTX MRTX 734,343 $60.4m734.3k shares
MACROGENICS INC MGNX MGNX 6,103,594 $53.8m6.1m shares
NOVAVAX INC NVAX NVAX 692,794 $51.0m692.8k shares
CENTESSA PHARMACEUTICALS PLC 3,577,094 $32.1m3.6m shares
CHEMOCENTRYX INC CCXI CCXI 1,155,964 $29.0m1.2m shares
KALVISTA PHARMACEUTICALS INC KALV KALV 1,930,322 $28.5m1.9m shares
EDGEWISE THERAPEUTICS INC EWTX EWTX 2,613,623 $25.4m2.6m shares
TANGO THERAPEUTICS INC TNGX TNGX 2,250,000 $17.1m2.2m shares
CHINOOK THERAPEUTICS INC ADRO ADRO 1,000,000 $16.4m1.0m shares
SCPHARMACEUTICALS INC SCPH SCPH 2,658,583 $15.1m2.7m shares
KALA PHARMACEUTICALS INC 10,874,613 $15.0m10.9m shares
GRAPHITE BIO INC GRPH GRPH 2,698,369 $13.8m2.7m shares
CYTEIR THERAPEUTICS INC 3,350,506 $12.6m3.4m shares
MORPHIC HLDG INC MORF MORF 278,874 $11.2m278.9k shares
AKOUOS INC 2,281,249 $10.8m2.3m shares
ALLOVIR INC 1,440,525 $9.7m1.4m shares
VERVE THERAPEUTICS INC 310,284 $7.1m310.3k shares
CUE HEALTH INC HLTHQ HLTHQ 750,000 $4.8m750.0k shares
PHASEBIO PHARMACEUTICALS INC PHAS PHAS 2,850,000 $3.8m2.9m shares
CULLINAN THERAPEUTICS INC CGEM CGEM 350,000 $3.7m350.0k shares
TSCAN THERAPEUTICS INC TCRX TCRX 1,021,764 $2.9m1.0m shares
COMPASS THERAPEUTICS INC CMPX CMPX 532,958 $730.0k533.0k shares

Stakes above 5%

Companies where this manager has reported owning more than 5% of a class of shares, on Schedule 13D (may seek influence) or 13G (passive): its latest filing for each, from 19 Dec 2024 on. The largest 25 of 77.

CompanyTickerStakeChange ScheduleLast filed
ARTIVA BIOTHERAPEUTICS INC ARTV · 13D · filed 2026-07-23 ARTV 37.9%≈ $178.6m +1.3 pts 13D 2026-07-23
CLIMB BIO INC CLYM · 13D · filed 2026-07-07 CLYM 33.0%≈ $271.9m no change 13D 2026-07-07
VOR BIOPHARMA INC 13D · filed 2025-06-27 31.8% -0.1 pts 13D 2025-06-27
ACUMEN PHARMACEUTICALS INC ABOS · 13D · filed 2026-03-17 ABOS 29.5%≈ $56.3m +4.7 pts 13D 2026-03-17
PEPGEN INC PEPG · 13D · filed 2025-09-30 PEPG 29.2%≈ $36.2m 13D 2025-09-30
ACRIVON THERAPEUTICS INC ACRV · 13D · filed 2026-04-23 ACRV 28.8%≈ $21.9m +7.2 pts 13D 2026-04-23
SPYGLASS PHARMA INC SGP · 13D · filed 2026-02-17 SGP 24.1%≈ $178.6m new 13D 2026-02-17
PARABILIS MEDICINES INC PBLS · 13D · filed 2026-06-18 PBLS 23.8%≈ $791.9m new 13D 2026-06-18
TYRA BIOSCIENCES INC TYRA · 13D · filed 2026-09-17 TYRA 19.9%≈ $417.2m -1.3 pts 13D 2026-09-17
VOR BIOPHARMA INC VOR · 13D · filed 2026-07-21 VOR 19.9%≈ $238.2m no change 13D 2026-07-21
JANUX THERAPEUTICS INC JANX · 13D · filed 2025-03-10 JANX 19.9%≈ $183.9m 13D 2025-03-10
WAVE LIFE SCIENCES LTD 96663EUR · 13D · filed 2026-04-17 96663EUR 17.1%≈ $198.9m -0.4 pts 13D 2026-04-17
Wave Life Sciences Inc. WVE · 13D · filed 2026-08-11 WVE 16.8% 13D 2026-08-11
HEMAB THERAPEUTICS HLDGS INC COAG · 13G · filed 2026-05-11 COAG 16.6%≈ $283.9m new 13G 2026-05-11
SIONNA THERAPEUTICS INC SION · 13D · filed 2026-09-21 SION 14.3%≈ $284.9m -8.3 pts 13D 2026-09-21
LENZ THERAPEUTICS INC LENZ · 13D · filed 2025-11-07 LENZ 13.6%≈ $24.2m -1.5 pts 13D 2025-11-07
SOLID BIOSCIENCES INC SLDB · 13D · filed 2026-06-24 SLDB 11.9%≈ $120.2m +2.0 pts 13D 2026-06-24
SEPTERNA INC SEPN · 13D · filed 2026-08-14 SEPN 11.8%≈ $185.0m 13D 2026-08-14
BICARA THERAPEUTICS INC BCAX · 13D · filed 2026-03-02 BCAX 11.5%≈ $216.1m 13D 2026-03-02
ARS PHARMACEUTICALS INC SPRY · 13D · filed 2025-10-01 SPRY 11.1%≈ $87.6m 13D 2025-10-01
CORBUS PHARMACEUTICALS HLDGS CRBP · 13G · filed 2026-09-30 CRBP 9.9%≈ $18.0m new 13G 2026-09-30
ADICET BIO INC ACET · 13G · filed 2026-08-14 ACET 9.9%≈ $8.1m -2.4 pts 13G 2026-08-14
GERON CORP GERN · 13G · filed 2026-08-14 GERN 9.9%≈ $85.1m no change 13G 2026-08-14
OVID THERAPEUTICS INC OVID · 13G · filed 2026-08-14 OVID 9.9%≈ $52.6m no change 13G 2026-08-14
RANI THERAPEUTICS HLDGS INC RANI · 13G · filed 2026-08-14 RANI 9.9%≈ $8.8m no change 13G 2026-08-14

Trades reported as a company insider in Q2 2022

Owning 10% or more of a company, or having someone on its board, makes this manager an insider there: it reports its trades in that company's shares on Form 4 within two business days. Open-market and private purchases and sales only.

DateCompanyTickerTradeShares ValueTheir holding
2022-06-21 AN2 THERAPEUTICS INC 10% owner · See footnotes ANTX Bought 302 $2.4k302 shares +<1%
2022-06-16 Wave Life Sciences Inc. Director · See Footnotes WVE Bought 9,480,052 $20.4m9.5m shares +123%
2022-06-14 AN2 THERAPEUTICS INC 10% owner · See footnotes ANTX Bought 61,424 $489.5k61.4k shares +2%
2022-06-13 AN2 THERAPEUTICS INC 10% owner · See footnotes ANTX Bought 20,000 $158.0k20.0k shares +0%
2022-05-26 KALA BIO INC 10% owner · See Footnotes KALA Sold 1,005,686 $362.0k1.0m shares -12%
2022-05-25 KALA BIO INC 10% owner · See Footnotes KALA Sold 1,434,509 $602.5k1.4m shares -15%
2022-05-24 KALA BIO INC 10% owner · See Footnotes KALA Sold 144,805 $73.9k144.8k shares -2%
2022-05-23 KALA BIO INC 10% owner · See Footnotes KALA Sold 1,250,000 $812.5k1.2m shares -12%
2022-05-10 PEPGEN INC Director · See footnotes PEPG Bought 3,229,200 $38.8m3.2m shares new
2022-04-26 NKARTA INC Director · See Footnotes NKTX Bought 2,200,000 $33.0m2.2m shares +39%